Patients with coronavirus disease 2019 (COVID-19) pneumonia can develop hypoxaemic
acute respiratory failure (hARF) with the need for positive end-expiratory pressure (PEEP). …

… Thoracic Endoscopy, Campus Bio Medico University and Teaching Hospital, Rome),
Andrea Comel, UO Pneumologia, Ospedale Pederzoli, Peschiera del Garda); Japan: Kiyoyasu …

CAP may be diagnosed and followed up by lung sonography (LUS), a technique that shows
excellent sensitivity and specificity that is at least comparable with that of chest X-ray in two …

Over the last years CFTR (cystic fibrosis transmembrane conductance regulator) modulators
have shown the ability to improve relevant clinical outcomes in patients with cystic fibrosis (…

Background Tracheostomy is one of the most common surgical procedures performed in
critical care patient management; more specifically, ventilation through tracheal cannula allows …

The role of neutrophil elastase (NE) is poorly understood in bronchiectasis because of the
lack of preclinical data and so most of the assumptions made about NE inhibitor potential …

Introduction The Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of
Pulmonology (SIP) constituted an expert panel for developing evidence-based guidance for the …

Rationale: Emerging data support the existence of a microbial “gut-lung” axis that remains
unexplored in bronchiectasis. Methods: Prospective and concurrent sampling of gut (stool) …

Cystic fibrosis (CF) has entered the era of variant-specific therapy, tailored to the genetic
variants in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene. CFTR …

Bronchiectasis is a heterogeneous chronic disease. Heterogeneity characterises bronchiectasis
not only in the stable state but also during exacerbations, despite evidence on clinical …